Home Stock

Stock Research: Arteris

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Arteris

NMQ:AIP US04302A1043
38
  • Value
    4
  • Growth
    87
  • Safety
    Safety
    22
  • Combined
    22
  • Sentiment
    100
  • 360° View
    360° View
    38
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Arteris, Inc. is a provider of semiconductor system IP, including interconnect and other intellectual property, (collectively, System IP) technology. Its System IP technology manages the on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. It provides semiconductor interconnect IP and SoC Integration Automation software solutions to serve its target end-markets, including automotive, enterprise computing, consumer electronics, communications across wired and wireless, and industrial markets. Its two core product platforms are Network-on-Chip IP Products and SoC Integration Automation Software Solutions Products. Its Network-on-Chip IP products include Non-coherent NoC IP, with FlexGen, FlexNoC and FlexWay; Cache-coherent NoC IP, with Ncore, and NoC interface IP, with CodaCache. Its SoC Integration Automation Software Solutions products include IP and SoC software, with Magillem (Connectivity and Registers) and CSRCompiler.

more

ANALYSIS: With an Obermatt 360° View of 38 (better than 38% compared with alternatives), overall professional sentiment and financial characteristics for the stock Arteris are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Arteris. The consolidated Growth Rank has a good rank of 87, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 87% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 100, which means that professional investors are more optimistic about the stock than for 100% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 4, which means that the share price of Arteris is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 96% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 22, which means that the company has a financing structure that is riskier than those of 78% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Strongest Rank Price vs. Earnings (P/E)
Weakest Rank Sentiment
Country USA
Industry Systems Software
Size Small
Website arteris.com
Index
NASDAQ
Arteris stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 10-Aug-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
4 25 34 61
Growth
87 81 43 21
Safety
Safety
22 18 58 20
Sentiment
100 43 51 59
360° View
360° View
38 18 37 47
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
100 36 72 64
Opinions Change
99 72 50 50
Pro Holdings
n/a 9 21 61
Market Pulse
97 68 61 30
Sentiment
100 43 51 59
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
4 25 34 61
Growth
87 81 43 21
Safety Safety
22 18 58 20
Combined
22 18 21 55
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
7 49 64 36
Price vs. Earnings (P/E)
1 20 20 55
Price vs. Book (P/B)
3 2 21 96
Dividend Yield
1 1 1 1
Value
4 25 34 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
94 74 26 85
Profit Growth
13 88 6 10
Capital Growth
66 20 97 17
Stock Returns
97 89 47 43
Growth
87 81 43 21
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
73 54 70 36
Refinancing
27 35 67 7
Liquidity
4 1 1 51
Safety Safety
22 18 58 20

Similar Stocks

Discover high‑ranked alternatives to Arteris and broaden your portfolio horizons.

ResMed

NYQ:RMD
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Global Payments

NYQ:GPN
Country: USA
Industry: Other Financial Services
Size: X-Large
Full Stock Analysis

Merck (USA)

NYQ:MRK
Country: USA
Industry: Pharmaceuticals
Size: XX-Large
Full Stock Analysis

Micron

NSQ:MU
Country: USA
Industry: Semiconductors
Size: XX-Large
Full Stock Analysis

Frequently Asked
Questions

This is a classic, high-risk growth play: high growth and positive sentiment outweigh low Value Rank (expensive) and risky financing. This is for aggressive growth investors who are comfortable with the high price and risk, believing the growth story justifies the expense.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews